Inventor · disambiguated record
Jeremie Xavier G. Mortier
Also filed as: MORTIER JEREMIE XAVIER · MORTIER JEREMIE XAVIER G · MORTIER JÉRÉMIE XAVIER · MORTIER JÉRÉMIE XAVIER G
2 granted patents·9 pending applications·4 citations·filing 2018–2023
43Inventor score
Top patents by PatentIndex Score
11 records- 0185US11447504B2Macrocyclic chlorine substituted indole derivativesBAYER AG·Filed 2018·Granted Sep 20, 2022·3 cites·14 claims
- 0274US12227501B23-amino-2-[2-(acylamino)pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one as CSNK1 inhibitorsBAYER AG·Filed 2020·Granted Feb 18, 2025·1 cites·15 claims
- 0360US2023416249A1N-[2-({4-[3-(anilino)-4-oxo-4,5,6,7-tetrahydro-1h-pyrrolo[3,2-c]pyridin-2-yl]pyridin-3-yl)oxy)ethyl]prop-2-enamide derivatives and similar compounds as egfr inhibitors for the treatment of cancerBAYER AG·Filed 2023·Application pending·0 cites
- 0458US2025154170A1Fused pyrimidines as kras inhibitorsBAYER AG·Filed 2023·Application pending·0 cites
- 0556US2023064983A13-(anilino)-2-[3-(3-alkoxy-pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one derivatives as egfr inhibitors for the treatment of cancerBAYER AG·Filed 2022·Application pending·0 cites
- 0654US2025188075A1Substituted heterocyclic csnk1 inhibitorsBROAD INST INC·Filed 2023·Application pending·0 cites
- 0753US2023357239A1Pyrido[2,3-d]pyrimidin-4-amines as sos1 inhibitorsBAYER AG·Filed 2021·Application pending·0 cites
- 0849US2023365554A1Substituted pyrrolo-pyridinone derivatives and therapeutic uses thereofBROAD INST INC·Filed 2021·Application pending·0 cites
- 0948US2023322767A1Aryl substituted pyrrolo-pyridinones and therapeutic uses thereofBAYER AG·Filed 2021·Application pending·0 cites
- 1048US2022227729A1Identification and use of kras inhibitorsBAYER AG·Filed 2020·Application pending·0 cites
- 1147US2023391769A1Substituted heterocyclic compounds and therapeutic uses thereofBAYER AG·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jeremie Xavier G. Mortier files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →